BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...
(RTTNews) - Haemonetics Corp. (HAE) on Thursday announced that it has received 510(k) clearance from the FDA for the new TEG 6s Hemostasis analyzer system Global Hemostasis-HN assay cartridge. This ...
BRAINTREE, Mass., Nov. 20, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient ...
Haemonetics Corporation remains a Buy, supported by robust profit margins, strong cash flow, and leading TEG and plasma businesses driving organic growth. HAE reported improved gross and operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results